• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于纳米材料的药物载体的设计与开发,利用不同的传输机制来克服血脑屏障。

Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms.

机构信息

School of Biomedical Engineering, University of Western Ontario, 1151 Richmond Str., London, ON N6A 5B9, Canada.

Department of Chemical and Biochemical Engineering, University of Western Ontario, 1151 Richmond Str., London, ON N6A 5B9, Canada.

出版信息

Int J Mol Sci. 2021 Sep 19;22(18):10118. doi: 10.3390/ijms221810118.

DOI:10.3390/ijms221810118
PMID:34576281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8465340/
Abstract

Central nervous system (CNS) diseases are the leading causes of death and disabilities in the world. It is quite challenging to treat CNS diseases efficiently because of the blood-brain barrier (BBB). It is a physical barrier with tight junction proteins and high selectivity to limit the substance transportation between the blood and neural tissues. Thus, it is important to understand BBB transport mechanisms for developing novel drug carriers to overcome the BBB. This paper introduces the structure of the BBB and its physiological transport mechanisms. Meanwhile, different strategies for crossing the BBB by using nanomaterial-based drug carriers are reviewed, including carrier-mediated, adsorptive-mediated, and receptor-mediated transcytosis. Since the viral-induced CNS diseases are associated with BBB breakdown, various neurotropic viruses and their mechanisms on BBB disruption are reviewed and discussed, which are considered as an alternative solution to overcome the BBB. Therefore, most recent studies on virus-mimicking nanocarriers for drug delivery to cross the BBB are also reviewed and discussed. On the other hand, the routes of administration of drug-loaded nanocarriers to the CNS have been reviewed. In sum, this paper reviews and discusses various strategies and routes of nano-formulated drug delivery systems across the BBB to the brain, which will contribute to the advanced diagnosis and treatment of CNS diseases.

摘要

中枢神经系统(CNS)疾病是世界范围内导致死亡和残疾的主要原因。由于血脑屏障(BBB)的存在,有效地治疗 CNS 疾病极具挑战性。它是一种具有紧密连接蛋白和高选择性的物理屏障,限制了血液和神经组织之间的物质运输。因此,了解 BBB 的转运机制对于开发新型药物载体以克服 BBB 具有重要意义。本文介绍了 BBB 的结构及其生理转运机制。同时,综述了基于纳米材料的药物载体通过 BBB 的不同策略,包括载体介导、吸附介导和受体介导的转胞吞作用。由于病毒诱导的 CNS 疾病与 BBB 破坏有关,因此还综述和讨论了各种神经嗜性病毒及其破坏 BBB 的机制,这被认为是克服 BBB 的一种替代解决方案。因此,还综述和讨论了用于穿透 BBB 进行药物递送的病毒模拟纳米载体的最新研究。另一方面,还综述了载药纳米载体向 CNS 的给药途径。总之,本文综述和讨论了纳米药物递送系统穿透 BBB 进入大脑的各种策略和途径,这将有助于 CNS 疾病的高级诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/744fc2ec5301/ijms-22-10118-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/df4a44bd9dd9/ijms-22-10118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/5d0557bad85a/ijms-22-10118-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/4d5ea048c368/ijms-22-10118-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/b3730366c107/ijms-22-10118-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/2bf0b429e067/ijms-22-10118-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/0899cbcc39b4/ijms-22-10118-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/744fc2ec5301/ijms-22-10118-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/df4a44bd9dd9/ijms-22-10118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/5d0557bad85a/ijms-22-10118-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/4d5ea048c368/ijms-22-10118-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/b3730366c107/ijms-22-10118-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/2bf0b429e067/ijms-22-10118-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/0899cbcc39b4/ijms-22-10118-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/8465340/744fc2ec5301/ijms-22-10118-g007.jpg

相似文献

1
Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms.基于纳米材料的药物载体的设计与开发,利用不同的传输机制来克服血脑屏障。
Int J Mol Sci. 2021 Sep 19;22(18):10118. doi: 10.3390/ijms221810118.
2
Transcellular brain drug delivery: A review on recent advancements.细胞间脑内药物递送:近期进展综述。
Int J Pharm. 2020 Aug 30;586:119582. doi: 10.1016/j.ijpharm.2020.119582. Epub 2020 Jun 26.
3
Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.基于纳米材料的血脑屏障(BBB)穿越策略。
Biomaterials. 2019 Dec;224:119491. doi: 10.1016/j.biomaterials.2019.119491. Epub 2019 Sep 14.
4
Nano carriers for drug transport across the blood-brain barrier.用于药物穿越血脑屏障运输的纳米载体。
J Drug Target. 2017 Jan;25(1):17-28. doi: 10.1080/1061186X.2016.1184272. Epub 2016 May 19.
5
Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.穿越血脑屏障:脑内药物递送的最新进展
CNS Drugs. 2017 Feb;31(2):109-133. doi: 10.1007/s40263-016-0405-9.
6
Functionalized Nanomaterials Capable of Crossing the Blood-Brain Barrier.具有穿透血脑屏障能力的功能化纳米材料。
ACS Nano. 2024 Jan 23;18(3):1820-1845. doi: 10.1021/acsnano.3c10674. Epub 2024 Jan 9.
7
Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.纳米载体的进步使药物能够穿透血脑屏障靶向递送到大脑。
Int J Pharm. 2019 Mar 25;559:360-372. doi: 10.1016/j.ijpharm.2019.01.056. Epub 2019 Feb 2.
8
Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials.纳米材料经血脑屏障递药至脑内。
Small. 2017 Nov;13(43). doi: 10.1002/smll.201701921. Epub 2017 Oct 16.
9
Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.中枢神经系统癌症的细胞和分子靶向药物递送:靶向策略的进展。
Curr Top Med Chem. 2020;20(30):2762-2776. doi: 10.2174/1568026620666200826122402.
10
Blood-Brain Barrier (BBB)-Crossing Strategies for Improved Treatment of CNS Disorders.血脑屏障(BBB)穿越策略,改善中枢神经系统疾病的治疗。
Handb Exp Pharmacol. 2024;284:213-230. doi: 10.1007/164_2023_689.

引用本文的文献

1
Pharmacological mechanisms and potential clinical applications of Dihydromyricetin in neurological disorders.二氢杨梅素在神经疾病中的药理机制及潜在临床应用
Front Pharmacol. 2025 Jul 16;16:1618623. doi: 10.3389/fphar.2025.1618623. eCollection 2025.
2
Crossing the Blood-Brain Barrier: Innovations in Receptor- and Transporter-Mediated Transcytosis Strategies.穿越血脑屏障:受体介导和转运体介导的转胞吞作用策略的创新
Pharmaceutics. 2025 May 28;17(6):706. doi: 10.3390/pharmaceutics17060706.
3
Development of Brain Permeable Drugs and Novel Strategies to Overcome the Brain Barriers for Treatment Purposes.

本文引用的文献

1
Transport of small molecules through the blood-brain barrier: biology and methodology.小分子通过血脑屏障的转运:生物学与方法学
Adv Drug Deliv Rev. 1995 Jul;15(1-3):5-36.
2
Lactoferrin and Its Detection Methods: A Review.乳铁蛋白及其检测方法综述。
Nutrients. 2021 Jul 22;13(8):2492. doi: 10.3390/nu13082492.
3
A viral journey to the brain: Current considerations and future developments.病毒侵袭大脑之旅:当前思考与未来发展
用于治疗目的的脑渗透性药物的开发及克服血脑屏障的新策略。
Curr Pharm Des. 2025 Apr 21. doi: 10.2174/0113816128386983250410092649.
4
From Molecules to Mind: The Critical Role of Chitosan, Collagen, Alginate, and Other Biopolymers in Neuroprotection and Neurodegeneration.从分子到思维:壳聚糖、胶原蛋白、藻酸盐及其他生物聚合物在神经保护和神经退行性变中的关键作用
Molecules. 2025 Feb 22;30(5):1017. doi: 10.3390/molecules30051017.
5
Metal nanoparticles in neuroinflammation: impact on microglial dynamics and CNS function.神经炎症中的金属纳米颗粒:对小胶质细胞动力学和中枢神经系统功能的影响。
RSC Adv. 2025 Feb 18;15(7):5426-5451. doi: 10.1039/d4ra07798a. eCollection 2025 Feb 13.
6
A comprehensive insight of innovations and recent advancements in nanocarriers for nose-to-brain drug targeting.纳米载体用于鼻脑靶向给药的创新与最新进展综述
Des Monomers Polym. 2025 Feb 10;28(1):7-29. doi: 10.1080/15685551.2025.2464132. eCollection 2025.
7
Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies.推进中枢神经系统治疗:通过基于纳米颗粒的基因和酶替代疗法改善神经系统疾病。
Int J Nanomedicine. 2025 Feb 4;20:1443-1490. doi: 10.2147/IJN.S457393. eCollection 2025.
8
Oleanolic Acid Cubic Liquid Crystal Nanoparticle-Based Thermosensitive Gel Attenuates Depression Symptoms in Chronic Unpredictable Mild Stress Rats.基于齐墩果酸立方液晶纳米颗粒的热敏凝胶减轻慢性不可预测轻度应激大鼠的抑郁症状
Drug Des Devel Ther. 2025 Feb 1;19:715-736. doi: 10.2147/DDDT.S484567. eCollection 2025.
9
Nanoparticle Interactions with the Blood Brain Barrier: Insights from Drosophila and Implications for Human Astrocyte Targeted Therapies.纳米颗粒与血脑屏障的相互作用:来自果蝇的见解及对人类星形胶质细胞靶向治疗的启示
Neurochem Res. 2025 Jan 20;50(1):80. doi: 10.1007/s11064-025-04333-x.
10
Core-shell upconversion nanoparticles with suitable surface modification to overcome endothelial barrier.具有适当表面修饰以克服内皮屏障的核壳型上转换纳米颗粒。
Discov Nano. 2024 Nov 12;19(1):181. doi: 10.1186/s11671-024-04139-w.
PLoS Pathog. 2020 May 21;16(5):e1008434. doi: 10.1371/journal.ppat.1008434. eCollection 2020 May.
4
SARS-CoV-2: "Three-steps" infection model and CSF diagnostic implication.严重急性呼吸综合征冠状病毒2(SARS-CoV-2):“三步”感染模型及脑脊液诊断意义
Brain Behav Immun. 2020 Jul;87:128-129. doi: 10.1016/j.bbi.2020.05.002. Epub 2020 May 5.
5
SARS-CoV-2 can induce brain and spine demyelinating lesions.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)可诱发脑和脊髓脱髓鞘病变。
Acta Neurochir (Wien). 2020 Jul;162(7):1491-1494. doi: 10.1007/s00701-020-04374-x. Epub 2020 May 4.
6
Does SARS-Cov-2 invade the brain? Translational lessons from animal models.SARS-CoV-2 是否侵犯大脑?动物模型的转化研究。
Eur J Neurol. 2020 Sep;27(9):1764-1773. doi: 10.1111/ene.14277. Epub 2020 May 22.
7
Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的中枢神经系统受累。
J Med Virol. 2020 Jul;92(7):699-702. doi: 10.1002/jmv.25915.
8
Tailored mesoporous silica nanosystem with enhanced permeability of the blood-brain barrier to antagonize glioblastoma.具有增强血脑屏障通透性以对抗胶质母细胞瘤的定制介孔二氧化硅纳米系统。
J Mater Chem B. 2016 Sep 28;4(36):5980-5990. doi: 10.1039/c6tb01329e. Epub 2016 Aug 30.
9
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.SARS-CoV-2 刺突糖蛋白的特征及其对病毒进入的影响,以及与 SARS-CoV 的免疫交叉反应性。
Nat Commun. 2020 Mar 27;11(1):1620. doi: 10.1038/s41467-020-15562-9.
10
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.新型冠状病毒(COVID-19)感染中枢神经系统的证据:组织分布、宿主-病毒相互作用及潜在神经嗜性机制。
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998. doi: 10.1021/acschemneuro.0c00122. Epub 2020 Mar 13.